[
  {
    "date": "2022-12-30",
    "symbol": "AVIR",
    "period": "FY",
    "entityregistrantname": "ATEA PHARMACEUTICALS, INC.",
    "tradingsymbol": "AVIR",
    "entitycentralindexkey": 1593899,
    "currentfiscalyearenddate": "December 31",
    "entityfilercategory": "Accelerated filer",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": " December 31, 2022",
    "entitysmallbusiness": "false",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entitytaxidentificationnumber": "46-0574869",
    "entityfilenumber": "001-39661",
    "entityaddressaddressline1": "225 Franklin Street",
    "entityaddressaddressline2": "Suite 2100",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2110,
    "cityareacode": 857,
    "localphonenumber": "284-8891",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "true",
    "auditorfirmid": 185,
    "auditorname": "KPMG LLP",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 188460000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 458249000,
    "prepaidexpenseandotherassetscurrent": 1060000,
    "assetscurrent": 660922000,
    "propertyplantandequipmentnet": 1705000,
    "restrictedcashnoncurrent": 198000,
    "otherassetsnoncurrent": 1494000,
    "operatingleaserightofuseasset": 2389000,
    "assets": 666708000,
    "accountspayablecurrent": 2551000,
    "accruedliabilitiesandotherliabilities": 15206000,
    "operatingleaseliabilitycurrent": 721000,
    "liabilitiescurrent": 18478000,
    "operatingleaseliabilitynoncurrent": 2403000,
    "accruedincometaxesnoncurrent": 5255000,
    "liabilities": 26136000,
    "commonstockvalue": 83000,
    "additionalpaidincapital": 701052000,
    "accumulatedothercomprehensiveincomelossnetoftax": -684000,
    "retainedearningsaccumulateddeficit": -59879000,
    "stockholdersequity": -59879000,
    "liabilitiesandstockholdersequity": 666708000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 81936000,
    "generalandadministrativeexpense": 7000000,
    "operatingexpenses": 130650000,
    "operatingincomeloss": -130650000,
    "interestandotherincome": 11151000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -119499000,
    "incometaxexpensebenefit": -3590000,
    "netincomeloss": -115909000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -684000,
    "comprehensiveincomenetoftax": -116593000,
    "earningspersharebasic": -1.39,
    "earningspersharediluted": -1.39,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 230000,
    "stockissuedduringperiodsharesstockoptionsexercised": 155873,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 140000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 29036,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 46718000,
    "othercomprehensiveincomelossnetoftax": -684000,
    "profitloss": -115909000,
    "sharebasedcompensation": 46718000,
    "depreciationandamortization": 260000,
    "amortizationofdebtdiscountpremium": -5465000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 6251000,
    "increasedecreaseinotheroperatingassets": 1494000,
    "increasedecreaseinaccountspayable": -1983000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -37623000,
    "increasedecreaseinoperatingleaseliability": 765000,
    "netcashprovidedbyusedinoperatingactivities": -120982000,
    "paymentstoacquirepropertyplantandequipment": 1943000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 545352000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 91885000,
    "netcashprovidedbyusedininvestingactivities": -455410000,
    "proceedsfromstockoptionsexercised": 230000,
    "proceedsfromstockplans": 140000,
    "netcashprovidedbyusedinfinancingactivities": 370000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -576022000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 188658000,
    "restrictedcash": 198000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 2938000,
    "cashcashequivalentsandshortterminvestments": 646709000,
    "commissionrate": 0.03,
    "capitalizedcontractcostamortizationmethod": "The Company has elected the practical expedient in ASC 340, Other Assets and Deferred Costs, wherein it recognizes the incremental costs of obtaining a contract as an expense when incurred if, at inception, the expected amortization period of the asset that the Company otherwise would have recognized is one year or less.",
    "retainagedeposit": 1494000,
    "sharebasedcompensationarrangementpercentageofpurchasepricelesserofmarketpriceonofferingdateorpurchasedate": 0.85,
    "sharebasedcompensationarrangementpercentageofdiscountonpurchasepriceofcommonstock": 0.15,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "Two years",
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining lease term",
    "researchanddevelopmentcreditadjustment": 6898000,
    "cashandcashequivalentsfairvaluedisclosure": 167584000,
    "availableforsalesecuritiesdebtsecurities": 458249000,
    "assetsfairvaluedisclosure": 625833000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 458933000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 684000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionnumberofpositions": 15,
    "debtsecuritiesavailableforsaleunrealizedlosspositionaccumulatedloss": 684000,
    "debtsecuritiesavailableforsaleunrealizedlossposition": 143221000,
    "propertyplantandequipmentgross": 1978000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 273000,
    "accruedresearchanddevelopmentexpenseincludingmanufacturingandclinicalexpenditurescurrent": 7667000,
    "accruedincometaxescurrent": 99000,
    "employeerelatedliabilitiescurrent": 6459000,
    "accruedprofessionalfeesandothercurrent": 981000,
    "operatingleasecost": 811000,
    "variableleasecost": 78000,
    "leasecost": 889000,
    "lesseeoperatingleaseremainingleaseterm": 4,
    "lesseeoperatingleasediscountrate": 0.031000000000000003,
    "locationofofficespace": "Boston, Massachusetts",
    "operatingleaseliability": 3124000,
    "leaseexpirationmonthandyear": "July 2022",
    "lessoroperatingleaseexistenceofoptiontoextend": "no",
    "operatingleaseexpense": 811000,
    "bankdepositrestrictedcash": 198000,
    "milestonepayments": 300000000,
    "consultingagreementsuccessfeepayout": 5000000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 805000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 821000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 838000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 855000,
    "lesseeoperatingleaseliabilitypaymentsdue": 3319000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 195000,
    "commonstockvotingrights": "On all matters to be voted upon by the holders of common stock, holders of common stock are entitled to one vote per share.",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesauthorized": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 742070,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedinperiodaggregategrantdatefairvalue": 5298000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardvestingnumberofinstallments": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 17100,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 724970,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "ten years",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 92798,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsmethodused": "Black-Scholes",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 7.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 7.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 613738,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 18.48,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.08,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 25.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 18.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 16.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 7.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 10937000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 10937000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 10348000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.021,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.85,
    "allocatedsharebasedcompensationexpense": 145000,
    "operatinglosscarryforwards": 30030000,
    "taxcreditcarryforwardamount": 1294000,
    "operatinglosscarryforwardsexpirationyear": 2034,
    "taxcreditcarryforwardexpirationyear": 2034,
    "deferredtaxassetsvaluationallowance": 41156000,
    "incometaxexaminationdescription": "The Company evaluates tax positions for recognition using a more-likely-than-not recognition threshold, and those tax positions eligible for recognition are measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon the effective settlement with a taxing authority that has full knowledge of all relevant information.",
    "unrecognizedtaxbenefits": 5255000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.055999999999999994,
    "effectiveincometaxratereconciliationreturntoprovisionadjustments": 0.034,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.021,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.038,
    "effectiveincometaxratereconciliationuncertaintaxpositions": -0.002,
    "effectiveincometaxratereconciliationotheradjustments": 0.003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.253,
    "effectiveincometaxratecontinuingoperations": 0.031000000000000003,
    "deferredtaxassetsinprocessresearchanddevelopment": 14305000,
    "deferredtaxassetsoperatinglosscarryforwards": 5590000,
    "deferredtaxassetslicenseagreement": 6043000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 12215000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3826000,
    "deferredtaxassetsother": 70000,
    "deferredtaxassetsprepaidexpenses": -893000,
    "deferredtaxassetsgross": 41156000,
    "unrecognizedtaxbenefitsdecreasesresultingfromcurrentperiodtaxpositions": 943000,
    "unrecognizedtaxbenefitsincreasesresultingfromaccruedinterest": 266000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.04,
    "definedcontributionplancostrecognized": 541000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 1000
  },
  {
    "date": "2021-12-30",
    "symbol": "AVIR",
    "period": "FY",
    "entityregistrantname": "ATEA PHARMACEUTICALS, INC.",
    "tradingsymbol": "AVIR",
    "entitycentralindexkey": 1593899,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large accelerated filer",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "entitysmallbusiness": "false",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entitytaxidentificationnumber": "46-0574869",
    "entityfilenumber": "001-39661",
    "entityaddressaddressline1": "125 Summer Street",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2110,
    "cityareacode": 857,
    "localphonenumber": "284-8891",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "true",
    "auditorfirmid": 185,
    "auditorname": "KPMG LLP",
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 764375000,
    "prepaidexpenseandotherassetscurrent": 8028000,
    "assetscurrent": 772403000,
    "propertyplantandequipmentnet": 23000,
    "otherassetsnoncurrent": 466000,
    "assets": 772892000,
    "accountspayablecurrent": 4534000,
    "accruedliabilitiesandotherliabilities": 10417000,
    "liabilitiescurrent": 56883000,
    "otherliabilitiesnoncurrent": 5932000,
    "liabilities": 62815000,
    "commonstockvalue": 83000,
    "additionalpaidincapital": 653964000,
    "retainedearningsaccumulateddeficit": 56030000,
    "stockholdersequity": 56030000,
    "liabilitiesandstockholdersequity": 772892000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 351367000,
    "researchanddevelopmentexpense": 25000000,
    "generalandadministrativeexpense": 7000000,
    "operatingexpenses": 212990000,
    "operatingincomeloss": 138377000,
    "interestandotherincome": 213000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 138590000,
    "incometaxexpensebenefit": 17400000,
    "netincomeloss": 121190000,
    "earningspersharebasic": 1.46,
    "earningspersharediluted": 1.37,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 1465000,
    "stockissuedduringperiodsharesstockoptionsexercised": 665793,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 39621000,
    "profitloss": 121190000,
    "sharebasedcompensation": 39621000,
    "depreciationandamortization": 29000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 483000,
    "increasedecreaseinotheroperatingassets": 161000,
    "increasedecreaseinaccountspayable": 10289000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 43877000,
    "increasedecreaseincontractwithcustomerliability": -301367000,
    "netcashprovidedbyusedinoperatingactivities": -87005000,
    "paymentstoacquirepropertyplantandequipment": 4000,
    "netcashprovidedbyusedininvestingactivities": -4000,
    "proceedsfromissuanceofcommonstock": 1465000,
    "netcashprovidedbyusedinfinancingactivities": 1465000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -85544000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 764680000,
    "restrictedcash": 305000,
    "milestonepaymentreceived": 50000000,
    "capitalizedcontractcostamortizationmethod": "The Company has elected the practical expedient in ASC 340, Other Assets and Deferred Costs, wherein it recognizes the incremental costs of obtaining a contract as an expense when incurred if, at inception, the expected amortization period of the asset that the Company otherwise would have recognized is one year or less.",
    "bankdepositrestrictedcash": 305000,
    "operatingleaserightofuseasset": 161000,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "Two years",
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining lease term",
    "collaborativeagreementtransactionprice": 350000000,
    "costsreimbursedamount": 7264000,
    "cashandcashequivalentsfairvaluedisclosure": 731767000,
    "propertyplantandequipmentgross": 184000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 161000,
    "accruedresearchanddevelopmentexpenseincludingmanufacturingandclinicalexpenditurescurrent": 18080000,
    "accruedlicensefeescurrent": 25000000,
    "accruedincometaxescurrent": 2572000,
    "employeerelatedliabilitiescurrent": 4209000,
    "accruedprofessionalfeesandothercurrent": 2488000,
    "operatingleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OtherAssets",
    "operatingleaseliabilitycurrent": 197000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent",
    "operatingleasecost": 281000,
    "variableleasecost": 37000,
    "leasecost": 318000,
    "lesseeoperatingleaseremainingleaseterm": "P6M",
    "lesseeoperatingleasediscountrate": 0.07,
    "operatingleaseexpense": 318000,
    "milestonepayments": 300000000,
    "consultingagreementsuccessfeepayout": 5000000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 989000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 805000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 821000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 838000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 855000,
    "lesseeoperatingleaseliabilitypaymentsdue": 4308000,
    "commonstockvotingrights": "On all matters to be voted upon by the holders of common stock, holders of common stock are entitled to one vote per share.",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "ten years",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 128036000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 39.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsmethodused": "Black-Scholes",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 296313,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 22.87,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 55.14,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 24.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 22.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 31239000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 23500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 31239000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.85,
    "allocatedsharebasedcompensationexpense": 39621000,
    "currentincometaxexpensebenefit": 17400,
    "operatinglosscarryforwards": 9000,
    "operatinglosscarryforwardsexpirationyear": 2034,
    "taxcreditcarryforwardexpirationyear": 2034,
    "utilizedoperatinglosscarryforward": 52820000,
    "utilizedresearchanddevelopmenttaxcreditcarryforwards": 665000,
    "deferredtaxassetsvaluationallowance": 10904000,
    "valuationallowancedeferredtaxassetchangeinamount": -6081000,
    "amountofannuallimitonuseofnetoperatinglossesandothertax": 169000,
    "incometaxexaminationdescription": "The Company evaluates tax positions for recognition using a more-likely-than-not recognition threshold, and those tax positions eligible for recognition are measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon the effective settlement with a taxing authority that has full knowledge of all relevant information.",
    "unrecognizedtaxbenefits": 5932000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.032,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.040999999999999995,
    "effectiveincometaxratereconciliationtaxcreditsforeign": 0.061,
    "effectiveincometaxratereconciliationuncertaintaxpositions": 0.043,
    "effectiveincometaxratereconciliationotheradjustments": -0.013999999999999999,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.044000000000000004,
    "effectiveincometaxratecontinuingoperations": 0.125,
    "deferredtaxassetslicenseagreement": 6261000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 5643000,
    "deferredtaxassetsother": 256000,
    "deferredtaxassetsprepaidexpenses": -1256000,
    "deferredtaxassetsgross": 10904000,
    "weightedaveragenumberdilutedsharesoutstandingadjustment": "null",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.04,
    "definedcontributionplancostrecognized": 272000,
    "relatedpartytransactionentitycontrolledbydirectornumber": "one",
    "retainagedeposit": 110000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 67000
  },
  {
    "date": "2020-12-30",
    "symbol": "AVIR",
    "period": "FY",
    "entityregistrantname": "ATEA PHARMACEUTICALS, INC.",
    "tradingsymbol": "AVIR",
    "entitycentralindexkey": 1593899,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "entitysmallbusiness": "false",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entitycurrentreportingstatus": "Yes",
    "entitytaxidentificationnumber": "46-0574869",
    "entityfilenumber": "001-39661",
    "entityaddressaddressline1": "125 Summer Street",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2110,
    "cityareacode": 857,
    "localphonenumber": "284-8891",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "cashandcashequivalentsatcarryingvalue": 850117000,
    "unbilledreceivablescurrent": 5815000,
    "prepaidexpenseandotherassetscurrent": 7545000,
    "assetscurrent": 863477000,
    "propertyplantandequipmentnet": 48000,
    "otherassetsnoncurrent": 107000,
    "assets": 863632000,
    "accountspayablecurrent": 60000,
    "accruedliabilitiesandotherliabilities": 14368000,
    "deferredrevenuecurrent": 301367000,
    "liabilitiescurrent": 315795000,
    "otherliabilitiesnoncurrent": 36000,
    "liabilities": 315831000,
    "commonstockvalue": 82000,
    "additionalpaidincapital": 612879000,
    "retainedearningsaccumulateddeficit": -65160000,
    "stockholdersequity": -65160000,
    "liabilitiesandstockholdersequity": 863632000,
    "temporaryequityparorstatedvaluepershare": 0.001,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 82436937,
    "commonstocksharesoutstanding": 82436937,
    "revenuefromcontractwithcustomerexcludingassessedtax": 48633000,
    "researchanddevelopmentexpense": 2086000,
    "generalandadministrativeexpense": 7000000,
    "operatingexpenses": 59663000,
    "operatingincomeloss": -11030000,
    "interestandotherincome": 83000,
    "netincomeloss": -10947000,
    "earningspersharebasicanddiluted": -0.51,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 21592441,
    "sharesoutstanding": 82436937,
    "temporaryequitystockissuedduringperiodvaluenewissues": 107485000,
    "temporaryequitystockissuedduringperiodsharesnewissues": 8973261,
    "stockissuedduringperiodvaluestockoptionsexercised": 27000,
    "stockissuedduringperiodsharesstockoptionsexercised": 18747,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrestrictedstockunitsrequisiteserviceperiodrecognition": 657000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 20000,
    "stockissuedduringperiodvaluenewissues": 317605000,
    "stockissuedduringperiodsharesnewissues": 14375000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 283230000,
    "conversionofstocksharesconverted1": -57932090,
    "conversionofstockamountconverted1": 283230000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 57932090,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6800000,
    "stockissuancecosts": 3245000,
    "profitloss": -10947000,
    "sharebasedcompensation": 7457000,
    "depreciationandamortization": 19000,
    "increasedecreaseinaccountsreceivable": 5815000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 7296000,
    "increasedecreaseinaccountspayable": -488000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 12437000,
    "increasedecreaseincontractwithcustomerliability": 301367000,
    "netcashprovidedbyusedinoperatingactivities": 296734000,
    "paymentstoacquirepropertyplantandequipment": 26000,
    "netcashprovidedbyusedininvestingactivities": -26000,
    "proceedsfromissuanceofconvertiblepreferredstock": 214116000,
    "proceedsfromissuanceofcommonstock": 27000,
    "proceedsfromissuanceinitialpublicoffering": 317605000,
    "netcashprovidedbyusedinfinancingactivities": 531748000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 828456000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 850224000,
    "restrictedcash": 107000,
    "capitalizedcontractcostamortizationmethod": "The Company has elected the practical expedient in ASC 340, Other Assets and Deferred Costs, wherein it recognizes the incremental costs of obtaining a contract as an expense when incurred if, at inception, the expected amortization period of the asset that the Company otherwise would have recognized is one year or less.",
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "P2Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining lease term",
    "collaborativeagreementtransactionprice": 350000000,
    "capitalizedcontractcostnet": 7000000,
    "revenueremainingperformanceobligation": 301367000,
    "costsreimbursedamount": 7901000,
    "cashandcashequivalentsfairvaluedisclosure": 846701000,
    "propertyplantandequipmentgross": 180000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 132000,
    "accruedresearchanddevelopmentexpenseincludingmanufacturingandclinicalexpenditurescurrent": 10546000,
    "accruedprofessionalfeesandothercurrent": 1079000,
    "employeerelatedliabilitiescurrent": 2743000,
    "leaseexpirationdate1": "2022-07-31",
    "operatingleaseexpense": 303000,
    "consultingagreementsuccessfeepayout": 5000000,
    "operatingleasesfutureminimumpaymentsduecurrent": 340000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 200000,
    "operatingleasesfutureminimumpaymentsdue": 540000,
    "commonstockvotingrights": "On all matters to be voted upon by the holders of common stock, holders of common stock are entitled to one vote per share.",
    "commonstockcapitalsharesreservedforfutureissuance": 7059000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 180000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P10Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 33240000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 14.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsmethodused": "Black-Scholes",
    "allocatedsharebasedcompensationexpense": 1951000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7917783,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 4613861,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 588964,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3246548,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 7917783,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.68,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 14.93,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 6.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 1.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 6.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 277894000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 129531000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 277894000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0031,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0056,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.917,
    "operatinglosscarryforwards": 25675000,
    "taxcreditcarryforwardamount": 274000,
    "netoperatinglossescarriedbackperiod": "P2Y",
    "netoperatinglossescarriedforwardperiod": "P20Y",
    "operatinglosscarryforwardsexpirationyear": 2033,
    "taxcreditcarryforwardexpirationyear": 2031,
    "operatinglosscarryforwardsoffsetpercentofannualtaxableincome": 0.8,
    "deferredtaxassetsvaluationallowance": 16985000,
    "valuationallowancedeferredtaxassetchangeinamount": 1888000,
    "amountofannuallimitonuseofnetoperatinglossesandothertax": 169000,
    "incometaxexaminationlikelihoodofunfavorablesettlement": "greater than 50%",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.026,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.125,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.136,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.173,
    "deferredtaxassetsoperatinglosscarryforwards": 14069000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1072000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1791000,
    "deferredtaxassetsother": 53000,
    "deferredtaxassetsgross": 16985000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7917783,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 43000
  }
]